Sources of Variability in Biomarker Concentrations

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 17, Issue 1, 2014, Pages 45-61

  Aylward, Lesa L ^a   Hays, Sean M ^a   Smolders, Roel ^b   Koch, Holger M ^c   Cocker, John ^d   Jones, Kate ^d   Warren, Nicholas ^d   Levy, Len ^e   Bevan, Ruth ^e  

^a LLP   (United States)

^b FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d HEALTH AND SAFETY LABORATORY   (United Kingdom)

^e CRANFIELD UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE;

ABSORPTION; BIOACCUMULATION; BIOLOGICAL MONITORING; BLOOD LEVEL; CREATININE URINE LEVEL; ELIMINATION HALF-LIFE; EXCRETION; EXPOSURE VARIABLE; HUMAN; KIDNEY CONCENTRATING CAPACITY; LIPID BLOOD LEVEL; METABOLIC RATE; REVIEW; TOXICOKINETICS; URINE FLOW RATE; URINE LEVEL; BLOOD; ENVIRONMENTAL EXPOSURE; URINE;

BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; HUMANS;

EID: 84898784874     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937404.2013.864250     Document Type: Review

References (54)

1. Angerer, J., Aylward, L. L., Hays, S. M., Heinzow, B., and Wilhelm, M. 2011. Human biomonitoring assessment values: Approaches and data requirements. Int. J. Hyg. Environ. Health. 214: 348-360.
2. Aylward, L. L., Kirman, C. R., Adgate, J. L., McKenzie, L. M., and Hays, S. M. 2012. Interpreting variability in population biomonitoring data: Role of elimination kinetics. J. Expos. Sci. Environ. Epidemiol. 22: 398-408.
3. Barr, D. B., Wilder, L. C., Caudill, S. P., Gonzalez, A. J., Needham, L. L., and Pirkle, J. L. 2005. Urinary creatinine concentrations in the U.S. Population: Implications for urinary biologic monitoring measurements. Environ. Health Perspect. 113: 192-200.
4. Berlin, C. M., LaKind, J. S., Fenton, S. E., Wang, R. Y., Bates, M. N., Brent, R. L., Condon, M., Crase, B. L., Dourson, M. L., Ettinger, A. S., Foos, B., Furst, P., Giacoia, G. P., Goldstein, D. A., Haynes, S. G., Hench, K. D., Kacew, S., Koren, G., Lawrence, R. A., Mason, A., McDiarmid, M. A., Moy, G., Needham, L. L., Paul, I. M., Pugh, L. C., Qian, Z., Salamone, L., Selevan, S. G., Sonawane, B., Tarzian, A. J., Rose Tully, M., and Uhl, K. 2005. Conclusions and recommendations of the expert panel: Technical workshop on human milk surveillance and biomonitoring for environmental chemicals in the United States. J. Toxicol. Environ. Health A 68: 1825-1831.
5. Bevan, R., Angerer, J., Cocker, J., Jones, K., Koch, H. M., Sepai, O., Schoeters, G., Smolders, R., and Levy, L. 2012. Framework for the development and application of environmental biological monitoring guidance values. Regul. Toxicol. Pharmacol. 63: 453-460.
6. Boeniger, M .F., Lowry, L. K., and Rosenberg, J. 1993. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: A review. Am. Ind. Hyg. Assoc. J. 54: 615-627.
7. Bradman, A., Kogut, K., Eisen, E. A., Jewell, N. P., Quiros-Alcala, L., Castorina, R., Chevrier, J., Holland, N. T., Barr, D. B., Kavanagh-Baird, G., and Eskenazi, B. 2013. Variability of organophosphorous pesticide metabolite levels in spot and 24-hr urine samples collected from young children during 1 week. Environ. Health Perspect. 121: 118-124.
8. D'Eon, J. C., Simpson, A. J., Kumar, R., Baer, A. J., and Mabury, S. A. 2010. Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy. Environ. Toxicol. Chem. 29: 1678-1688.
9. Dai, X., Kutschke, K., and Priest, N. 2011. Rapid urinary output normalization method using specific gravity. Health Phys. 101: 140-143.
10. Dorne, J. L. 2007. Human variability in hepatic and renal elimination: Implications for risk assessment. J. Appl. Toxicol. 27: 411-420.
11. Esteban, M., and Castano, A. 2009. Noninvasive matrices in human biomonitoring: A review. Environ. Int. 35: 438-449.
12. Frederiksen, H., Kranich, S. K., Jorgensen, N., Taboureau, O., Petersen, J. H., and Andersson, A. M. 2013. Temporal variability in urinary phthalate metabolite excretion based on spot, morning, and 24-h urine samples: Considerations for epidemiological studies. Environ. Sci. Technol. 47: 958-967.
13. Gentry, P. R., Hack, C. E., Haber, L., Maier, A., Clewell, H. J. 3rd. 2002. An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: Examples with warfarin and parathion. Toxicol. Sci. 70: 120-139.
14. Goellner, M. H., Ziegler, E. E., and Fomon, S. J. 1981. Urination during the first three years of life. Nephron 28: 174-178.
15. Hays, S. M., Aylward, L. L., Driver, J., Ross, J., and Kirman, C. 2012. 2, 4-D exposure and risk assessment: Comparison of external dose and biomonitoring based approaches. Regul. Toxicol. Pharmacol. 64: 481-489.
16. Hays, S. M., and Aylward, L. L. 2003. Dioxin risks in perspective: Past, present, and future. Regul. Toxicol. Pharmacol. 37: 202-217.
17. Heavner, D. L., Morgan, W. T., Sears, S. B., Richardson, J. D., Byrd, G. D., and Ogden, M. W. 2006. Effect of creatinine and specific gravity normalization techniques on xenobiotic biomarkers in smokers' spot and 24-h urines. J. Pharm. Biomed. Anal. 40: 928-942.
18. Heffernan, A. L., Aylward, L. L., Toms, L. M. L., Eaglesham, G., Hobson, P., Sly, P.D., and Mueller, J. F. 2013. Age-related trends in urinary excretion of bisphenol A in Australian children and adults: Evidence from a pooled sample study using samples of convenience. J. Toxicol. Environ. Health A 76: 1039-1055.
19. Huber, D. R., Blount, B. C., Mage, D. T., Letkiewicz, F. J., Kumar, A., and Allen, R. H. 2011. Estimating perchlorate exposure from food and tap water based on us biomonitoring and occurrence data. J. Expos. Sci. Environ. Epidemiol. 21: 395-407.
20. Jones, A. W. 2006. Urine as a biological specimen for forensic analysis of alcohol and variability in the urine-to-blood relationship. Toxicol. Rev. 25: 15-35.
21. Kedderis, G. L., and Held, S. D. 1996. Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats, mice, and humans. Toxicol. Appl. Pharmacol. 140: 124-130.
22. Kedderis, G. L. 1997. Extrapolation of in vitro enzyme induction data to humans in vivo. Chem. Biol. Interact. 107: 109-121.
23. Koch, H. M., Kolossa-Gehring, M., Schröter- Kermani, C., Angerer, J., and Brüning, T. 2012 Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: A retrospective exposure evaluation. J. Expos. Sci. Environ. Epidemiol. 22: 610-616.
24. Koch, H. M., Lorber, M., Christensen, K. L. Y., Pälmke, C., Koslitz, S., and T. Brüning. 2013. Identifying sources of phthalate exposure with human biomonitoring: Results of a 48 hour fasting study with urine collection and personal activity patterns. Int. J. Hyg. Environ. Health. 216: 672-681.
25. LaKind, J. S., Brent, R. L., Dourson, M. L., Kacew, S., Koren, G., Sonawane, B., Tarzian, A. J., and Uhl, K. 2005. Human milk biomonitoring data: Interpretation and risk assessment issues. J. Toxicol. Environ. Health A 68: 1713-1769.
26. Li, Z., Romanoff, L. C., Lewin, M. D., Porter, E. N., Trinidad, D. A., Needham, L. L., et al. 2010. Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling. J. Expos. Sci. Environ. Epidemiol. 20: 526-535.
27. Mage, D. T., Allen, R. H., and Kodali, A. 2008. Creatinine corrections for estimating children's and adult's pesticide intake doses in equilibrium with urinary pesticide and creatinine concentrations. J. Expos. Sci. Environ. Epidemiol. 18: 360-368.
28. Moriguchi, J., Ezaki, T., Tsukahara, T., Fukui, Y., Ukai, H., Okamoto, S., Shimbo, S., Sakurai, H., and Ikeda, M. 2005. Decreases in urine specific gravity and urinary creatinine in elderly women. Int. Arch. Occup. Environ. Health 78: 438-445.
29. Morton, J., Cotton, R., Cocker, J., and Warren, N. D. 2010. Trends in blood lead levels analysed at the Health and Safety Laboratory, UK 1995-2007. Occup. Environ. Med. 67: 590-595.
30. Morton, J., Leese, E., Cotton, R., Warren, N., and Cocker, J. 2011. Beryllium in urine by ICP-MS-A comparison of low level exposed workers and unexposed persons. Int. Arch. Occup. Environ. Health 84: 697-704.
31. Nong, A., McCarver, D. G., Hines, R. N., and Krishnan, K. 2006. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: A case study with toluene. Toxicol. Appl. Pharmacol. 214: 78-87.
32. Patterson, D. G., Jr., Needham, L. L., Pirkle, J. L., Roberts, D. W., Bagby, J., Garrett, W. A., Andrews, J. S., Jr., Falk, H., Bernert, J. T., and Sampson, E .J. 1988. Correlation between serum and adipose tissue levels of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in 50 persons from Missouri. Arch. Environ. Contam. Toxicol. 17: 139-143.
33. Pelekis, M., Gephart, L. A., and Lerman, S. E. 2001. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds. Regul. Toxicol. Pharmacol. 33: 12-20.
34. Perrier, E., Vergne, S., Klein, A., Poupin, M., Rondeau, P., Le Bellego, L., Armstrong, L. E., Lang, F., Stookey, J., and Tack, I. 2013. Hydration biomarkers in free-living adults with different levels of habitual fluid consumption. Br. J. Nutr. 109: 1678-1687.
35. Phillips, D. L., Pirkle, J. L., Burse, V. W., Bernert, J. T., Jr., Henderson, L. O., and Needham, L. L. 1989. Chlorinated hydrocarbon levels in human serum: Effects of fasting and feeding. Arch. Environ. Contam. Toxicol. 18: 495-500.
36. Pleil, J. D. 2009. Influence of systems biology response and environmental exposure level on between-subject variability in breath and blood biomarkers. Biomarkers 14: 560-571.
37. Preau, J. L., Jr., Wong, L. Y., Silva, M. J., Needham, L. L., and Calafat, A. M. 2010. Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ. Health Perspect. 118: 1748-1754.
38. Remer, T., Neubert, A., and Maser-Gluth, C. 2002. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am. J. Clin. Nutr. 75: 561-569.
39. Ritter, R., Scheringer, M., MacLeod, M., Moeckel, C., Jones, K. C., and Hungerbuhler, K. 2011. Intrinsic human elimination halflives of polychlorinated biphenyls derived from the temporal evolution of crosssectional biomonitoring data from the United Kingdom. Environ. Health Perspect. 119: 225-231.
40. Ritter, R., Scheringer, M., MacLeod, M., Schenker, U., and Hungerbuhler, K. 2009. A multi-individual pharmacokinetic model framework for interpreting time trends of persistent chemicals in human populations: application to a post-ban situation. Environ. Health Perspect. 117: 1280-1286.
41. Scher, D. P., Sawchuk, R. J., Alexander, B. H., and Adgate, J. L. 2008. Estimating absorbed dose of pesticides in a field setting using biomonitoring data and pharmacokinetic models. J. Toxicol. Environ. Health A 71: 373-383.
42. Sexton, K., Needham, L. L., and Pirkle, J. L. 2004. Human biomonitoring of environmental chemicals. Am. Sci. 92: 38-45.
43. Smolders, R., Schramm, K.W., Nickmilder, M., and Schoeters G. 2009a. Applicability of non-invasively collected matrices for human biomonitoring. Environ. Health 8: 8-17.
44. Smolders, R., Schramm, K. W., Stenius, U., Grellier, J., Kahn, A., Trnovec, T., Sram, R., and Schoeters, G. 2009b. A review on the practical application of human biomonitoring in integrated environmental health impact assessment. J. Toxicol. Environ. Health B 12: 107-123.
45. Sobus, J. R., Pleil, J.D., McClean, M.D., Herrick, R. F., and Rappaport S. M. 2010. Biomarker variance component estimation for exposure surrogate selection and toxicokinetic inference. Toxicol. Lett. 199: 247-253.
46. Spaan, S., Fransman, W., Warren, N., Cotton, R., Cocker, J., and Tielemans, E. 2010. Variability of biomarkers in volunteer studies: The biological component. Toxicol. Lett. 198: 144-151.
47. Symanski, E., and Greeson, N. M. 2002. Assessment of variability in biomonitoring data using a large database of biological measures of exposure. Am. Ind. Hyg Assoc. J. 63: 390-401.
48. Tan, Y. M., Sobus, J., Chang, D., Tornero-Velez, R., Goldsmith, M., and Pleil, J. 2012. Reconstructing human exposures using biomarkers and other "clues." J. Toxicol. Environ. Health B 15: 22-38.
49. Trasande, L., Attina, T. M., and Blustein, J. 2012. Association between urinary bisphenol Aconcentration and obesity prevalence in children and adolescents. J. Am. Med. Assoc. 308: 1113-1121.
50. van Haarst, E. P., Heldeweg, E. A., Newling, D. W., and Schlatmann, T. J. 2004. The 24-h frequency-volume chart in adults reporting no voiding complaints: Defining reference values and analysing variables. Br. J. Urol. Int. 93: 1257-1261.
51. Volkel, W., Bittner, N., and Dekant, W. 2005. Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 33: 1748-1757.
52. Volkel, W., Kiranoglu, M., and Fromme, H. 2008. Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol. Lett. 179: 155-162.
53. Wielgomas, B. 2013. Variability of urinary excretion of pyrethroid metabolites in seven persons over seven consecutive days-Implications for observational studies. Toxicol. Lett. 221: 15-22.
54. Ye, X., Wong, L. Y., Bishop, A. M., and Calafat, A. M. 2011. Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ. Health Perspect. 119: 983-988.